Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Zynerba PharmaceuticalsLannettPhaseBio PharmaceuticalsGeronKamada
SymbolNASDAQ:ZYNENYSE:LCINASDAQ:PHASNASDAQ:GERNNASDAQ:KMDA
Price Information
Current Price$11.90$7.02$8.59$1.42$5.40
52 Week RangeBuyHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$25.00$9.00$19.6667$3.46$9.00
% Upside from Price Target110.08% upside28.21% upside128.95% upside143.66% upside66.67% upside
Trade Information
Market Cap$276.06 million$276.03 million$249.12 million$267.56 million$217.42 million
Beta4.852.41N/A2.591.17
Average Volume1,789,3851,327,391269,7502,450,48761,636
Sales & Book Value
Annual Revenue$90,000.00$684.56 million$670,000.00$1.07 million$114.47 million
Price / Sales3,067.290.40367.95250.061.90
CashflowN/A$4.7432 per shareN/AN/A$0.6569 per share
Price / CashN/A1.48N/AN/A8.22
Book Value$3.27 per share$15.76 per share$2.08 per share$0.95 per share$2.79 per share
Price / Book3.640.454.131.491.94
Profitability
Net Income$-39,910,000.00$28.69 million$-23,850,000.00$-27,020,000.00$22.30 million
EPS($2.61)$3.10($4.49)($0.16)$0.55
Trailing P/E RatioN/A2.26N/AN/A9.82
Forward P/E RatioN/A7.09N/AN/A11.49
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-39.84%-1,447.33%-5,328.80%21.10%
Return on Equity (ROE)-52.19%25.79%-193.85%-22.33%23.60%
Return on Assets (ROA)-46.10%7.55%-47.96%-21.47%19.05%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A2.10%0.12%N/A0.04%
Current Ratio9.37%2.88%16.51%16.86%4.74%
Quick Ratio9.37%2.12%16.52%16.86%3.40%
Ownership Information
Institutional Ownership Percentage19.25%82.07%59.97%31.37%15.86%
Insider Ownership Percentage10.79%12.57%17.00%7.50%N/A
Miscellaneous
Employees251,2512217408
Shares Outstanding23.20 million39.32 million28.70 million188.42 million40.26 million
Next Earnings Date11/14/2019 (Estimated)8/27/2019 (Confirmed)12/5/2019 (Estimated)11/7/2019 (Estimated)11/11/2019 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable
 Zynerba PharmaceuticalsLannettPhaseBio PharmaceuticalsGeronKamada

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel